All Stories

  1. Applying new tools to control tuberculosis
  2. Drug resistance mechanisms and drug susceptibility testing for tuberculosis
  3. Identification and Ranking of Clinical Compounds with Activity against Log-phase Growing Uropathogenic Escherichia coli
  4. Latent tuberculosis infection: Opportunities and challenges
  5. Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus
  6. Identification of Novel Mutations in LprG (rv1411c),rv0521,rv3630,rv0010c,ppsC, andcyp128Associated with Pyrazinoic Acid/Pyrazinamide Resistance inMycobacterium tuberculosis
  7. Tuberculosis updates 2018: Innovations and developments to end TB
  8. PhoU2 but Not PhoU1 as an Important Regulator of Biofilm Formation and Tolerance to Multiple Stresses by Participating in Various Fundamental Metabolic Processes in Staphylococcus epidermidis
  9. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis
  10. Disruption of Membrane by Colistin Kills Uropathogenic Escherichia coli Persisters and Enhances Killing of Other Antibiotics
  11. Mycobacterium tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid